Small molecule design and evaluation technology
Technology for the design of small molecule compounds that target the functional domains of proteins believed to be the underlying cause of specific disease indications. This inhibits a proteins activity by combining strength (with low toxicity) and selectiveness (for fewer side-effects). This technology also enables prediction of the drug's efficacy with precision equivalent to actual clinical trials.
 Molecular dynamics
A technique used to measure a substance's shape variation or volume of energy by calculating, over a certain period of time, the functional power among the atoms comprising a molecule. A large-scale supercomputer is needed to obtain a firm grasp of the human body's environment with its large molecular mass, including proteins, as the calculated volume increases exponentially depending on the number of atoms.
Software for designing small molecule compounds that target proteins underlying specific disease indications, binding to them more strongly and quickly than other molecules and thereby inhibiting their activity. It enables the design of many compounds with new structures that are unrelated to existing compound structures.
 MAPLE CAFEE
Software for predicting the activity of drug candidate compounds with a level of accuracy equivalent to biochemical assays. Based on high-precision molecular dynamics, it achieves world-class levels of accuracy.
RCAST (Research Center for Advanced Science and Technology) was established in 1987 and was formally acknowledged as the 11th research institute of the University of Tokyo. Its mission is to contribute to the development of science and technology by expeditiously taking on new challenges arising from the advancement of science and changes in society thereby exploring new areas of advanced science and technology for humankind and society. It is known for its uniqueness of cross-disciplinary research, and Laboratory for Systems Biology and Medicine(LSBM) led by Professor Kodama constitutes an important research domain of RCAST, dissecting the pathogenesis of cancer and atherosclerosis, diseases which are major causes of death and debility in many industrialized countries.
For more information, please see: http://www.rcast.u-tokyo.ac.jp/en/
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Over 170,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.5 trillion yen (US$55 billion) for the fiscal year ended March 31, 2011. For more information, please see http://www.fujitsu.com
Press ContactsPublic and Investor Relations Division
Company:RCAST, The University of Tokyo
All other company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.
This press release has been revised as of December 17, 2018.
Date: 10 June, 2011
Company: RCAST, The University of Tokyo, Fujitsu Limited, , , , , , , , ,